drug summary · 2 NDC codes
Zenzedi 5 mg/1
Dextroamphetamine Sulfate
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status ANDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | Dextroamphetamine Sulfate |
|---|---|
| active ingredients | DEXTROAMPHETAMINE SULFATE |
| dosage form | TABLET |
| route | ORAL |
| strength | 5 mg/1 |
| marketing status | ANDA |
| DEA schedule | CII |
| application number | ANDA090533 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Azurity Pharmaceuticals, Inc. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 24338-851 | — |
| 24338085103 | — |
Other Dextroamphetamine Sulfate products
6 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- Zenzedi 10 mg/1TABLET · Azurity Pharmaceuticals, Inc.
- Zenzedi 15 mg/1TABLET · Azurity Pharmaceuticals, Inc.
- Zenzedi 2.5 mg/1TABLET · Azurity Pharmaceuticals, Inc.
- Zenzedi 20 mg/1TABLET · Azurity Pharmaceuticals, Inc.
- Zenzedi 30 mg/1TABLET · Azurity Pharmaceuticals, Inc.
- Zenzedi 7.5 mg/1TABLET · Azurity Pharmaceuticals, Inc.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.